Literature DB >> 8380234

Acute lower respiratory illnesses during the first three years of life: potential roles for various etiologic agents. The Group Health Medical Associates.

C G Ray1, C J Holberg, L L Minnich, Z M Shehab, A L Wright, L M Taussig.   

Abstract

Lower respiratory tract illnesses (LRIs) occurring during the first 3 years of life among children enrolled in the Tucson Children's Respiratory Study have been studied for evidence of viral, mycoplasmal and Chlamydia trachomatis infections. This report examines those from whom adequate acute and convalescent sera were available at the time of the LRI. Two groups were compared: those in whom culture and/or antigen detection yielded an etiologic agent (N = 110); and those who did not (culture negative, N = 124). Seroconversions (> or = 4-fold titer rise) to respiratory syncytial virus; influenza virus types A and B; parainfluenza virus types 1, 2 and 3; or adenovirus were found in only 0 to 5% of the culture negative group. No significant differences between groups with regard to frequencies of seroconversion to influenza type C, parainfluenza virus type 4, human coronaviruses 229E and OC43 or cytomegalovirus were detected, which suggests that these agents may not be frequent primary causes of LRIs among otherwise healthy children. Significant differences in seroconversions to Epstein-Barr virus were detected, suggesting that Epstein-Barr virus may contribute to LRI morbidity; however, its exact role remains to be defined.

Entities:  

Mesh:

Year:  1993        PMID: 8380234     DOI: 10.1097/00006454-199301000-00004

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

1.  Simultaneous pulmonary infection with respiratory syncytial virus and human cytomegalovirus.

Authors:  C Zandotti; X N Delamballerie; C Vignoli; J M Garnier
Journal:  Arch Dis Child       Date:  1994-05       Impact factor: 3.791

2.  Viral agents causing lower respiratory tract infections in hospitalized children: evaluation of the Speed-Oligo® RSV assay for the detection of respiratory syncytial virus.

Authors:  W Sánchez-Yebra; J A Ávila-Carrillo; F Giménez-Sánchez; A Reyes-Bertos; M Sánchez-Forte; M Morales-Torres; A Rojas; J Mendoza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-06-02       Impact factor: 3.267

Review 3.  Viral upper respiratory tract infections in young children with emphasis on acute otitis media.

Authors:  Johanna Nokso-Koivisto; Tapani Hovi; Anne Pitkäranta
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2006-03-27       Impact factor: 1.675

4.  The impact of viral infections in children with community-acquired pneumonia.

Authors:  Chiara Mameli; Gian Vincenzo Zuccotti
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

5.  Epidemiologic Profile of Severe Acute Respiratory Infection in Brazil During the COVID-19 Pandemic: An Epidemiological Study.

Authors:  Nathália Mariana Santos Sansone; Matheus Negri Boschiero; Fernando Augusto Lima Marson
Journal:  Front Microbiol       Date:  2022-07-01       Impact factor: 6.064

6.  Immunohistochemistry analysis of pulmonary infiltrates in necropsy samples of children with non-pandemic lethal respiratory infections (RSV; ADV; PIV1; PIV2; PIV3; FLU A; FLU B).

Authors:  Victor Horácio de Souza Costa; Emanuele Baurakiades; Marina Louise Viola Azevedo; Gabriela Traiano; Jeana Kowal Rosales; Kelly Susana Kunze Larsen; Sonia Maria Raboni; Lucia de Noronha
Journal:  J Clin Virol       Date:  2014-07-03       Impact factor: 3.168

Review 7.  Pneumonia in the tropics.

Authors:  Tow Keang Lim; Wen Ting Siow
Journal:  Respirology       Date:  2017-08-01       Impact factor: 6.424

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.